BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27514530)

  • 1. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
    He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
    J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
    Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
    J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma.
    Zhou T; Gao Y
    World J Surg Oncol; 2016 Jan; 14(1):8. PubMed ID: 26758762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of LncRNA MIR31HG in human bladder cancer.
    He A; Chen Z; Mei H; Liu Y
    Cancer Biomark; 2016 Jul; 17(2):231-6. PubMed ID: 27434291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
    Shang C; Guo Y; Zhang H; Xue YX
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):507-13. PubMed ID: 26781446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
    Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
    Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA BANCR promotes proliferation and migration of lung carcinoma via MAPK pathways.
    Jiang W; Zhang D; Xu B; Wu Z; Liu S; Zhang L; Tian Y; Han X; Tian D
    Biomed Pharmacother; 2015 Feb; 69():90-5. PubMed ID: 25661343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.
    Xue S; Jiang SQ; Li QW; Wang S; Li J; Yang S; Zhang HM; Xu YF; Wang LS; Zheng JH
    BMC Urol; 2018 Sep; 18(1):79. PubMed ID: 30200918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
    Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
    Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
    Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated Long Noncoding RNA BANCR Promotes the Proliferation of Colorectal Cancer Cells via Downregualtion of p21 Expression.
    Shi Y; Liu Y; Wang J; Jie D; Yun T; Li W; Yan L; Wang K; Feng J
    PLoS One; 2015; 10(4):e0122679. PubMed ID: 25928067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
    Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
    Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of serine/threonine-protein kinase B-Raf-activated long-chain non-coding RNA on apoptosis and autophagy in thyroid carcinoma cells].
    Liu T; Zhao Y; Wang L; Jia H; Cui D; Si Y; Wang H; Xue H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):747-753. PubMed ID: 30124210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF activated non-coding RNA (BANCR) promoting gastric cancer cells proliferation via regulation of NF-κB1.
    Zhang ZX; Liu ZQ; Jiang B; Lu XY; Ning XF; Yuan CT; Wang AL
    Biochem Biophys Res Commun; 2015 Sep; 465(2):225-31. PubMed ID: 26248136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The YAP1 oncogene contributes to bladder cancer cell proliferation and migration by regulating the H19 long noncoding RNA.
    Li S; Yu Z; Chen SS; Li F; Lei CY; Chen XX; Bao JM; Luo Y; Lin GZ; Pang SY; Tan WL
    Urol Oncol; 2015 Oct; 33(10):427.e1-10. PubMed ID: 26163939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer.
    Xue Y; Ma G; Zhang Z; Hua Q; Chu H; Tong N; Yuan L; Qin C; Yin C; Zhang Z; Wang M
    Oncotarget; 2015 Jan; 6(1):484-93. PubMed ID: 25514464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.
    Zhang H; Guo Y; Song Y; Shang C
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):49-55. PubMed ID: 27878359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
    Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
    J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.